Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |